81. Congenital adrenal hyperplasia Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 87 / Drugs : 87 - (DrugBank : 23) / Drug target genes : 12 - Drug target pathways : 68
Congenital adrenal hyperplasia and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 81 | Congenital adrenal hyperplasia |
| 86 | Pulmonary arterial hypertension |
| 13 | Multiple sclerosis/Neuromyelitis optica |
| 6 | Parkinson disease |
| 67 | Polycystic kidney disease |
| 97 | Ulcerative colitis |
| 96 | Crohn disease |
| 50 | Dermatomyositis |
| 193 | Prader-Willi syndrome |
| 298 | Hereditary pancreatitis |
| 113 | Muscular dystrophy |
| 75 | Cushing disease |
| 49 | Systemic lupus erythematosus |
| 2 | Amyotrophic lateral sclerosis |
| 46 | Malignant rheumatoid arthritis |
| 78 | Hypopituitarism |
| 167 | Marfan syndrome |
| 58 | Hypertrophic cardiomyopathy |
| 90 | Retinitis pigmentosa |
| 226 | Interstitial cystitis with Hunners ulcer |
| 70 | Spinal stenosis |
| 65 | Primary immunodeficiency |
| 51 | Scleroderma |
| 77 | Growth hormone secreting pituitary adenoma |
| 83 | Addison disease |
| 265 | Lipodystrophy |
| 272 | Fibrodysplasia ossificans progressiva |
| 285 | Fanconi anemia |
| 60 | Aplastic anemia |
| 140 | Dorabe syndrome |
| 144 | Lennox-Gastaut syndrome |
| 222 | Primary nephrotic syndrome |
| 156 | Rett syndrome |
| 299 | Cystic fibrosis |
| 211 | Hypoplastic left heart syndrome |
| 220 | Rapidly progressive glomerulonephritis |
| 30 | Distal myopathy |